Development of clinical trial of E1A gene therapy targeting HER-2/neu-overexpressing breast and ovarian cancer.
Hung
M C
MC
Department of Cancer Biology, University of Texas M. D. Anderson Cancer Center, Houston 77030, USA. mchung@odin.mdacc.tmc.edu
Hortobagyi
G N
GN
Ueno
N T
NT
D017500:Adenovirus E1A Proteins / Q000235:genetics* / Q000378:metabolism; D000260:Adenoviruses, Human / Q000235:genetics* / Q000378:metabolism; D000818:Animals; D001943:Breast Neoplasms / Q000628:therapy*; D002986:Clinical Trials as Topic; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D016147:Genes, Tumor Suppressor; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D010051:Ovarian Neoplasms / Q000628:therapy*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics*
D017500:Adenovirus E1A Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases